This Warning From the CEO of the World's Biggest Vaccine Maker Could Be Bad News for Novavax
Pretty much everything seems to be going as hoped for Novavax (NASDAQ: NVAX) these days. The company reported great interim results from a U.K. late-stage study of its COVID-19 vaccine NVX-CoV2373 in late January. It's also completed enrollment in the U.S. and Mexico pivotal study. Novavax appears to be on track to win emergency use authorizations in the U.K., U.S., and other countries over the next few months.
But there's a potential problem on the horizon. Adar Poonawalla, CEO of the Serum Institute of India (SII), the world's largest vaccine maker, issued a warning last week that could be bad news for Novavax.
Image source: Getty Images.
Source Fool.com
